Serena Williams may not be done after all. The tennis icon has quietly taken a key step that could signal one of the most talked-about comebacks in sports: she’s officially rejoined the International Tennis Integrity Agency’s (ITIA) registered drug-testing pool — a move that’s compulsory for any athlete contemplating a return to professional competition.
For context, Williams, now 44, hasn’t played a sanctioned match since the 2022 US Open, where her thrilling run ended in the third round. Back then, she famously said she was “evolving away from tennis,” stopping short of calling it full retirement. Shortly afterward, she withdrew from the ITIA’s testing pool, which freed her from strict, year-round anti-doping protocols. But here’s the part most people don’t realize: to compete again under tennis’s global regulations, a player must stay available for random drug testing for six consecutive months before stepping onto a tournament court.
According to the ITIA’s updated list dated October 6, Williams’s name has reappeared in the official testing pool. A spokesperson for the agency confirmed that Serena herself requested re-entry, but they were careful to note this doesn’t automatically mean she’s planning to compete. It’s a procedural move — but one that sparks enormous curiosity.
So far, her camp has remained silent. Representatives for Williams haven’t responded to media inquiries, leaving fans and analysts reading between the lines. And this is where it gets particularly intriguing: the ITIA’s testing program isn’t a minor formality. It’s reserved mostly for the sport’s elite — top singles players, leading doubles teams, wheelchair stars, and veterans eyeing a serious comeback. In other words, Williams isn’t signing up just to hit casually; this is the same compliance path every returning pro must follow.
There’s long been quiet speculation that Williams might want one more taste of the US Open stage. During this year’s tournament, whispers rippled through the grounds that she could pop up in the mixed doubles draw — a fan-favorite exhibition that’s become a mini all-star event. But because she was officially classified as retired, the rules barred her from entering. Insiders also revealed that she actually tried to re-enter the testing pool earlier, in August, before the Open began. The thinking? She might reunite with her sister Venus for doubles. Unfortunately, the mandatory six-month testing window couldn’t be bypassed — the same regulation that once prevented Andy Roddick from a late-career cameo in 2014.
Venus, now 45, has taken a different route. She never retired formally, which spared her from the same red tape. Her 2025 comeback included an emotional singles win in Washington, a hard-fought match against No. 11 seed Karolína Muchová in New York, and a US Open doubles quarterfinal run alongside Leylah Fernandez. Venus is already set to continue her campaign in Auckland early next season.
So what does Serena’s move really mean? Her reinstatement doesn’t lock in a return, but it reactivates the countdown. If she remains in the testing program uninterrupted, she could, in theory, rejoin competition by mid-2026. Whether that means returning to singles glory, partnering Venus one last time, or simply keeping the door open for now — only Serena knows.
But here’s the question that’s dividing fans and analysts alike: is this the first hint of another Serena renaissance, or just a formality from someone who refuses to close the book completely? Could the GOAT of women’s tennis have one more surprise up her sleeve? What do you think — is this the calm before the comeback?
